Radical scavenging effect of different marine sponges from mediterranean coasts

Records of Natural Products

Volumn 7, Issue 2, 2013, Pages 96-104

  Aktas, Nihal ^a   Genc, Yasin ^b   Gozcelioglu, Bulent ^c   Konuklugil, Belma ^a   Sebnem Harput, U ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY   (Turkey)

Author keywords

Agelas; Axinella; Dysidea; Ircinia; Radical scavenging effect; Sponges

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; AGELAS OROIDES EXTRACT; ANTIOXIDANT; ASCORBIC ACID; AXINELLA CANNABINA EXTRACT; AXINELLA DAMICORNIS EXTRACT; AXINELLA VERRUCOSA EXTRACT; BUTYLATED HYDROXYANISOLE; CHONDRILLA NUCULA EXTRACT; CIOCALLYPTA CARBOLLOI EXTRACT; DYSIDEA AVARA EXTRACT; IRCINIA FASCICULATA EXTRACT; IRCINIA SPINULOSA EXTRACT; NITRIC OXIDE; PETROCIA FICIFORMIS EXTRACT; QUERCETIN; SARCOTRAGUS EXTRACT; SCAVENGER; SUPEROXIDE; UNCLASSIFIED DRUG;

AGELAS OROIDES; ANTIOXIDANT ACTIVITY; ARTICLE; AXINELLA CANNABINA; AXINELLA DAMICORNIS; AXINELLA VERRUCOSA; CHONDRILLA NUCULA; CIOCALLYPTA CARBOLLOI; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DYSIDEA AVARA; IC 50; IRCINIA FASCICULATA; IRCINIA SPINULOSA; MEDITERRANEAN SEA; PETROCIA FICIFORMIS; SARCOTRAGUS; SPONGE (PORIFERA); TURKEY (REPUBLIC);

AGELAS; AGELAS OROIDES; AXINELLA; AXINELLA CANNABINA; AXINELLA DAMICORNIS; DYSIDEA; DYSIDEA AVARA; IRCINIA; IRCINIA FASCICULATA;

EID: 84875413414     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. B. Halliwell (1994). Free radicals, antioxidants, and human disease: curiosity, cause, or consequence, Lancet. 344, 721-724.
2. E.A. Asongalem, H.S. Foyet and S. Ekobo (2004). Antiinflammatory, lack of central analgesia and antipyretic properties of Acanthus montanus (Ness) T. Anderson, J Ethnopharmacol. 95, 63-68.
3. M.S. Willis and F.H. Wians (2003). The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances, Clin Chim Acta. 330, 57-83.
4. F. Folmer, M. Jaspars, M. Dicato and M. Diederich (2008). Marine natural products as targeted modulators of the transcription factor NF-kB, Biochem Pharm. 75, 603-617.
5. M. Ferreira, A.G. Cabado, M. Chapela, P. Fajardo, M. Atanassova, A. Garrido, J.M. Vieites and J. Lago (2011). Cytotoxic activity of extracts of marine sponges from NW Spain on a neuroblastoma cell line, Env Tox Pharm. 32, 430-437.
6. M. Schumacher, M. Kelkel, M. Dicato and M. Diederich (2011). A Survey of Marine Natural Compounds and Their Derivatives with Anti-Cancer Activity Reported in 2010, Molecules. 16, 5629-5646.
7. N.K. Utkina, A.E. Makarchenko, O.V. Shchelokova and M.V. Virovaya (2004). Antioxidant activity of phenolic metabolites from marine sponges, Chem Nat Comp. 40, 373-377.
8. W. Watjen, A. Putz, Y. Chovolou, A. Kampkotter, F. Totzke, M.H.G. Kubbutat, P. Proksch and B. Konuklugil (2009). Hexa-, hepta-and nonaprenylhydroquinones isolated from marine sponges and inhibit NF-kB signalling in H4IIE cells, J Pharm Pharmacol. 61, 919-924.
9. E. Belarbi, A.C. Gomez, Y. Chisti, FG. Camacho and E.M. Grima (2003). Producing drugs from marine sponges, Biotechnology Advances. 21, 585-598.
10. M. Schumacher, M. Kelkel, M. Dicato and M. Diederich (2011). Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer, Biotechnol Adv. 29, 531-547.
11. T. Hatano, R. Edamatsu and M. Hiramatsu (1989). Effects of the interaction of tannins with co-existing substances. VI. Effects of tannins and related polyphenols on superoxide anion radical and on 1,1-diphenyl-2-picrylhydrazyl radical, Chem Pharm Bull. 37, 2016-2021.
12. U.S. Harput, O. Ari{dotless}kan, A.B. Iskit, A. Nagatsu and I. Saracoglu (2011). Antinociceptive, free radical-scavenging, and cytotoxic activities of Acanthus hirsutus Boiss, J Med Food. 14, 767-774.
13. K. Elizabeth and M.N.A. Rao (1990). Oxygen radical scavenging activity of curcumin, Int J Pharmacol. 58, 237-240.
14. P. Tsai, T.H. Tsai, C. Yu and S.C. Ho (2007). Comparison of NO-scavenging and NO-suppressing activities of different herbal teas with those of Green Tea, Food Chem. 103, 181-187.
15. U.S. Harput, Y. Genc, N. Khan and I. Saracoglu (2011). Radical scavenging effect of different Veronica species, Rec. Nat. Prod. 4, 100-107.
16. K. Hensley, S. Mou and Q.N. Pye (2003). Methods in pharmacology and toxicology: Methods in biological oxidative stress. Hensley K, Floyd RA, eds. Totowa, New Jersey, USA, Humana Press, 185-193.
17. R.K.K. Reddy, B.P. Reddy, S. Ramakrishna and P.V. Diwan (2008). Potential in vitro antioxidant and protective effects of Soymida febrifuga on ethanol induced oxidative damage in HepG2 cells, Food Chem Tox. 46, 3429-3442.
18. M. Valko, D. Leibfritz, J. Moncola, M.T.D. Cronin, M. Mazura and J. Telser (2007). Free radicals and antioxidants in normal physiological functions and human disease, Int J Biochem Cell Biol. 39, 44-84.
19. H. Margot, C. Acebal, E. Toril, R. Amils and J. Fernandez Puentes (2002). Consistent association of crenarchaeal Archaea with sponges of the genus Axinella, Marine Biol. 140, 739-745.
20. S. Nittala, M. Sarma, S.R. Krishna and S.R. Rao (2005). Sterol ring system oxidation pattern in marine sponges, Mar Drugs. 3, 84-111.
21. K. Chairman, A.J.A. Ranjit Singh and G. Alagumuthu (2012). Cytotoxic and antioxidant activity of selected marine sponges, Asian Pac J Trop Dis. 234-238.
22. I. Touati, K. Chaieb, A. Bakhrouf and K. Gaddour (2007). Screening of antimicrobial activity of marine sponge extracts collected from Tunisian coast, J Mycol Med. 17, 183-187.
23. I. Erdogan Orhan, B. Ozcelik, B. Konuklugil, A. Putz, U. Gokcen Kaban and P. Proksch (2012). Bioactivity screening of the selected Turkish marine sponges and three compounds from Agelas oroides, Rec. Nat. Prod. 6, 356-367.
24. D. Tasdemir, B. Topaloglu, R. Perozzo, R. Brun, R. O'Neill, N.M. Carballeira, X. Zhang, P.J. Tonge, A. Lindeng and P. Ruedi (2007). Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli, Bio Med Chem. 15, 6834-6845.
25. Y. Yamamoto and R.B. Gaynor (2001). Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer, J Clin Invest. 107,135-142.
26. M. Amigo, M. Paya, S. De Rosa and M.C. Terencio (2007). Antipsoriatic effects of avarol-30-thiosalicylate are mediated by inhibition of TNF-ttgeneration and NF-B activation in mouse skin, British J Pharm. 152, 353-365.
27. M. Amigo, M. Paya, A. Braza-Boil, S. De Rosa and M.C. Terencio (2008). Avarol inhibits TNF-α generation and NF-κB activation in human cells and in animal models, Life Sci. 82, 256-264.